Home Page_1-Chengda biotechnology

中 / EN



中文 EN

Dedicated to evolving into a Preeminent International-level Biopharmaceutical Company

Integrity & Trustworthiness, Benevolence & Harmony, Responsibility & Collaboration

Dedicatedly offer top-tier biological products, wholeheartedly safeguarding the life and health of humanity





About Us

Provide high-quality biological products to protect human life and health

Liaoning Chengda Biological Co., Ltd. was established in June 2002. The company takes "providing high-quality biological products and caring for human life and health" as its corporate mission, and always adheres to the core values of "integrity, benevolence, harmony, and cooperation". The corporate philosophy of "life, only responsibility" is committed to becoming an international excellent biopharmaceutical company. The main products are rabies vaccine for human use and inactivated Japanese encephalitis vaccine for human use.

Learn More

Over 2000 county-level CDCs

in marketing coverage

Over 30 countries and regions

in international markets

18 billion CNY

of operating income in 2023

3 Manufacturing bases

manufacturing and R&D facilities

2 R&D Centers

manufacturing and R&D Facilities

20 products

pipeline under development

Products

Market-launched Products 

Products in the Pipeline 

Inactivated Japanese Encephalitis Vaccine for Human Use (Vero cell) (IJEV)

SPEEDA-Rabies Vaccine for Human Use (Vero cell) (CPRV)

The News Window

Phase I clinical trial of the fifteen-valent HPV vaccine developed by Chengda Bio was officially launched.

Company News

2024-03-30

Chengda Biology's First "King Hegemony" Laws and Regulations Knowledge Contest Successfully Ends

Company News

2024-03-13

The fragrance of floral arts will bloom forever

Trade Union Activities

2024-03-08

China Vaccine Industry Association Rabies Prevention and Control 2023

The News Window

2023-11-24

The book scent keeps the beginning heart and shares the good things together.

Trade Union Activities

2023-11-22

The company's party committee organized outstanding collectives and individuals to go to Dalian red base to "recharge and store energy"

Party building work

2023-11-20





Learn more

Beijing Cheng Da Tianhe Biotechnology Co., Ltd.

Beijing Cheng Da Tianhe Biotechnology Co., Ltd., a wholly-owned subsidiary of Liaoning Cheng Da Biotechnology Co., Ltd. (CDBIO) is a modern state-controlled biotechnology company dedicated to the research and development (R&D) of innovative vaccines within the realm of biopharmaceuticals, whose business scope encompasses the technology development, technology services, technology consultations, and technology transfer of innovative vaccines in the biopharmaceutical field.

Learn more 

Cheng Da Biotechnology (Benxi) Co., Ltd.

CDBIO (Benxi) is a wholly-owned subsidiary of Liaoning Cheng Da Biotechnology Co., Ltd. (CDBIO)

Learn more 

Shenzhen Cheng Da Biotechnology Investment Co., Ltd.

Shenzhen Cheng Da Biotechnology Investment Co., Ltd. (CDBIO (Shenzhen)) is a wholly-owned subsidiary of Liaoning Cheng Da Biotechnology Co., Ltd. established in September 2023 with a registered capital of 200 million yuan. CDBIO (Shenzhen) is headquartered at the CVC Innovation Center for Listed Companies in Xiangmihu, Futian District, Shenzhen (the first CVC innovation service park for listed companies in China).

Learn more 